查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1588364

生物晶片市场规模、份额、趋势分析报告：按类型、最终用途、按地区、细分市场预测，2025-2030 年

Biochip Market Size, Share & Trends Analysis Report By Type (DNA Chips, Protein Chips, Lab-on-chip, Tissue Arrays, Cell Arrays), By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

生物晶片市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球生物晶片市场规模将达263亿美元，2025年至2030年复合年增长率为11.41%。

对药物发现和开发的需求不断增长，加上个人化医疗的采用，可能会推动产业成长。此外，世界各地生物技术公司越来越多地采用次世代定序正在推动产品需求。例如，2021 年 12 月，雅培的 i-STAT TBI 血浆测试获得了 CE 标誌，这是一种可携式创伤性脑损伤 (TBI) 血液分析仪。因此，该公司被允许扩大在欧盟（EU）的业务。定序技术的创新使研究人员能够将 DNA 分子解码至完整人类基因组的层次。

Thermo Fisher Scientific 的 Ion Torrent 晶片是一种基于合成序列的技术。该晶片是次世代定序(NGS) 技术的进步，使大规模并行定定序对于任何实验室来说都具有成本效益。因此，增强NGS应用的生物晶片的开发预计将支持该行业的成长。同样，增加政府推动国内生物晶片生产的倡议可能会支持未来几年的成长。这项策略性倡议旨在满足当地产品的需求和供应。例如，2022 年 7 月，SiPhox, Inc. 从 Baker-Polito 政府获得了价值 681,631 美元的津贴。

这笔资金将加速大规模生产可插拔光子生物晶片的製造设施的开发。为了满足药物发现、疫苗开发和分散式诊断等生物技术领域日益增长的需求，预计生物晶片的产量将从每月约100片加速至每月约5000片。此类投资可能会在未来几年补充产业成长。预计 COVID-19 大流行将对预测期内的行业成长产生积极影响。多家公司齐心协力开发创新解决方案来应对这场流行病。例如，2020 年 3 月，SkyWater Technology 宣布与华大智造合作，为 COVID-19 定序提供必要的组件，包括微射流微机电设备。

对个人化医疗日益增长的需求很可能成为未来几年该行业的重要应用领域。随着生物晶片逐渐成为分子诊断的重要组成部分，它们在照护现场诊断中的使用有望促进个人化医疗的发展。此外，使用微阵列进行基因表现分析有望推进基于分子分类的个人化癌症治疗。然而，生产生物晶片的成本相当高，导致最终用户的价格较高。例如，Josep Carreras 白血病研究所 (IJC) 为研究人员提供微阵列。 GeneChip Human Gene 2.0 ST 全转录本表达分析和新鲜样本的分析成本在 456 美元到 593 美元之间。

生物晶片市场报告亮点

  • 由于对快速准确检测癌症的需求很高，DNA 晶片类型在 2024 年占据最大的收益占有率。
  • 由于生物晶片有助于降低药物发现和开发的总体成本，实验室晶片药物发现应用领域预计在预测期内将以更快的速度增长。
  • 由于药物发现和开发的增加以及对个人化药物的需求，生物技术和製药最终用户细分市场在 2024 年获得了可观的收益占有率。
  • 由于对新兴企业和生物晶片应用开发的高研发投资和创业投资，北美在 2024 年占据了最大的收益占有率。
  • 预计 2025 年至 2030 年，亚太地区的复合年增长率将是最快的。这是由于地方政府为促进国内产品製造而采取的各种措施。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章 市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 产业分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19 影响分析

第四章集团业务类型分析

  • 类型细分仪表板
  • 生物晶片市场类型波动分析
  • 2018-2030年生物晶片市场规模与趋势分析（按类型）
  • DNA晶片
    • 2018-2030 年 DNA 晶片市场估计与预测
    • 癌症诊断和治疗
    • 基因表现
    • SNP基因型鉴定
    • 基因组学
    • 药物发现
    • 农业生物技术
    • 其他的
  • 蛋白质晶片
    • 2018-2030 年蛋白质晶片市场估计与预测
    • 蛋白质体学
    • 表达谱
    • 诊断
    • HTS
    • 药物发现
    • 其他的
  • 实验室晶片
    • 2018-2030 年实验室晶片市场估计与预测
    • 基因组学
    • 体外诊断和POC
    • 蛋白质体学
    • 药物发现
    • 其他的
  • 组织阵列
    • 2018-2030 年组织阵列市场估计与预测
  • 单元阵列
    • 2018-2030 年单元阵列市场估计与预测

第五章 依最终用途分类的业务分析

  • 最终用途细分仪表板
  • 生物晶片市场最终用途波动分析
  • 2018-2030 年生物晶片市场规模与趋势分析（依最终用途）
  • 生物技术和製药公司
  • 医院和诊断中心
  • 学术研究所
  • 其他的

第六章 区域业务分析（按类型、最终用途）

  • 区域仪表板
  • 2024年及2030年市场规模及预测与趋势分析
  • 北美洲
    • 北美生物晶片市场，2018-2030
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 欧洲生物晶片市场，2018-2030
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 亚太生物晶片市场，2018-2030
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 拉丁美洲生物晶片市场，2018-2030
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 中东和非洲生物晶片市场，2018-2030
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 公司分类
  • 策略规划
  • 2024 年企业市场分析
  • 公司简介
    • Agilent Technologies
    • PerkinElmer, Inc.
    • Illumina, Inc.
    • Bio-Rad Laboratories, Inc.
    • Standard BioTools Inc.
    • GE HealthCare
    • IBIOCHIPS
    • LI-COR, Inc.
    • Cellix Ltd
    • Randox Laboratories Ltd.
Product Code: GVR-1-68038-077-4

Biochip Market Growth & Trends:

The global biochip market size is estimated to reach USD 26.30 billion by 2030, expanding at a CAGR of 11.41% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rising requirement for drug discovery and development coupled with the adoption of personalized medicine is likely to favor the industry's growth. Furthermore, the rise in the implementation of next-generation sequencing by biotechnology companies around the globe is pushing product demand. For instance, in December 2021, Abbott received CE Mark for the i-STAT TBI Plasma test, a portable analyzer for Traumatic Brain Injury (TBI) blood. Hence, the company is permitted to expand its footprint in the European Union. The innovation in sequencing techniques has allowed researchers to decode DNA molecules up to the level of the complete human genome.

Ion Torrent chip by Thermo Fisher Scientific is one of the technologies based on sequencing by the technique of synthesis. The chip is an advancement in the Next-Generation Sequencing (NGS) technology that makes massively parallel sequencing cost-effective for every lab. Hence, the development of biochips to enhance the NGS application is anticipated to support the growth of the industry. Similarly, increasing government-based initiatives to promote the domestic production of biochips is likely to support the growth in the coming years. This strategic initiative is to match the local demand for the product with the supply. For instance, in July 2022, SiPhox, Inc. received a grant worth USD 681,631 from the Baker-Polito Administration.

The financial support is to accelerate the development of a manufacturing facility for the mass production of pluggable photonic biochips. It is estimated to accelerate the output to around 5,000 biochips per month from around 100 per month to match the rising demand from biotech segments including drug discovery, vaccine development, and distributed diagnostics. Such investments are likely to supplement the industry growth in the coming years. The COVID-19 pandemic is estimated to have a positive impact on industry growth during the forecasted period. Various companies collaborated to develop innovative solutions to deal with the pandemic. For instance, in March 2020, SkyWater Technology announced the collaboration with MGI, to supply essential components for COVID-19 sequencing, including microfluidic MEMS devices.

The growing requirement for personalized medicine is likely to become a key application area for the industry in the coming years. Since biochip is emerging as an important component in molecular diagnostics, their use in point-of-care diagnostics is anticipated to smooth the development of personalized medicines. In addition, gene expression profiling through microarrays is expected to enhance the progress of personalized treatment for cancer based on molecular classification. However, the cost involved in the manufacturing of biochips is considerably high, resulting in high pricing for end-users. For instance, Josep Carreras Leukaemia Research Institute (IJC) provides microarray to researchers. The cost of GeneChip Human Gene 2.0 ST for whole-transcript expression analysis & profiling ranges from USD 456 to 593 for fresh samples.

Biochip Market Report Highlights:

  • The DNA chips type segment accounted for the largest revenue share in 2024 due to the high demand for rapid and accurate detection of cancer
  • The drug discovery application segment for lab-on-chip is anticipated to grow at a faster rate during the forecast period as the biochip helps lower the overall cost of drug discovery & development
  • The biotechnology and pharmaceutical companies end-user segment captured a significant revenue share in 2024 due to the need for personalized medicines along with the increasing drug discovery & development
  • North America held the largest revenue share in 2024 owing to high R&D investment coupled with the accessibility of capital through venture capitalists for startups and the application development of biochips in the region
  • Asia Pacific is projected to register the fastest CAGR from 2025 to 2030 owing to various initiatives by local governments to promote domestic product manufacturing

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Type Segment
    • 1.1.2. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Primary Research
  • 1.6. Information or Data Analysis:
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Validation
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. List of Abbreviations
  • 1.11. Objective

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increase in adoption of next-generation sequencing
      • 3.2.1.2. Growing R&D in proteomics and genomics
      • 3.2.1.3. Presence of an extensive drug-development pipeline
      • 3.2.1.4. Increasing adoption of personalized medicine
      • 3.2.1.5. Rapid technological advances in biochip technology
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of manufacturing
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Type Group Business Analysis

  • 4.1. Type Segment Dashboard
  • 4.2. Biochip Market Type Movement Analysis
  • 4.3. Biochip Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. DNA Chips
    • 4.4.1. DNA chips market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Cancer Diagnosis and Treatment
      • 4.4.2.1. Cancer diagnosis and treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Gene Expression
      • 4.4.3.1. Gene expression market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. SNP Genotyping
      • 4.4.4.1. SNP genotyping market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.5. Genomics
      • 4.4.5.1. Genomics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.6. Drug Discovery
      • 4.4.6.1. Drug discovery market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.7. Agricultural Biotechnology
      • 4.4.7.1. Agricultural biotechnology market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.8. Others
      • 4.4.8.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5. Protein Chips
    • 4.5.1. Protein chips market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Proteomics
      • 4.5.2.1. Proteomics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Expression Profiling
      • 4.5.3.1. Expression profiling market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Diagnostics
      • 4.5.4.1. Diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.5. HTS
      • 4.5.5.1. HTS market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.6. Drug Discovery
      • 4.5.6.1. Drug discovery market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.7. Others
      • 4.5.7.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.6. Lab-on-chip
    • 4.6.1. Lab-on-chip market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.6.2. Genomics
      • 4.6.2.1. Genomics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.6.3. IVD & POC
      • 4.6.3.1. IVD & POC market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.6.4. Proteomics
      • 4.6.4.1. Proteomics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.6.5. Drug Discovery
      • 4.6.5.1. Drug discovery market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.6.6. Others
      • 4.6.6.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.7. Tissue Arrays
    • 4.7.1. Tissue arrays market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.8. Cell Arrays
    • 4.8.1. Cell arrays market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. End Use Business Analysis

  • 5.1. End Use Segment Dashboard
  • 5.2. Biochip Market End Use Movement Analysis
  • 5.3. Biochip Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Biotechnology & Pharmaceutical Companies
    • 5.4.1. Biotechnology & pharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5. Hospitals & Diagnostic Centers
    • 5.5.1. Hospitals & diagnostic centers market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.6. Academic & Research Institute
    • 5.6.1. Academic & research institute market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Regional Business Analysis by Type, End Use

  • 6.1. Regional Dashboard
  • 6.2. Market Size & Forecast and Trend Analysis, 2024 & 2030
  • 6.3. North America
    • 6.3.1. North America Biochip Market, 2018 - 2030 (USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Competitive Scenario
      • 6.3.2.3. Target Disease Prevalence
      • 6.3.2.4. U.S. Biochip Market, 2018 - 2030 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. Target Disease Prevalence
      • 6.3.3.4. Canada Biochip Market, 2018 - 2030 (USD Million)
    • 6.3.4. Mexico
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Competitive Scenario
      • 6.3.4.3. Target Disease Prevalence
      • 6.3.4.4. Mexico Biochip Market, 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. Europe Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.2. UK
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Target Disease Prevalence
      • 6.4.2.4. UK Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Target Disease Prevalence
      • 6.4.3.4. Germany Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. Target Disease Prevalence
      • 6.4.4.4. France Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Competitive Scenario
      • 6.4.5.3. Target Disease Prevalence
      • 6.4.5.4. Italy Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Competitive Scenario
      • 6.4.6.3. Target Disease Prevalence
      • 6.4.6.4. Spain Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.7. Denmark
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Competitive Scenario
      • 6.4.7.3. Denmark Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.8. Sweden
      • 6.4.8.1. Key Country Dynamics
      • 6.4.8.2. Competitive Scenario
      • 6.4.8.3. Target Disease Prevalence
      • 6.4.8.4. Sweden Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.9. Norway
      • 6.4.9.1. Key Country Dynamics
      • 6.4.9.2. Competitive Scenario
      • 6.4.9.3. Target Disease Prevalence
      • 6.4.9.4. Norway Biochip Market, 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Asia Pacific Biochip Market, 2018 - 2030 (USD Million)
    • 6.5.2. Japan
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Japan Biochip Market, 2018 - 2030 (USD Million)
    • 6.5.3. China
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. China Biochip Market, 2018 - 2030 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Target Disease Prevalence
      • 6.5.4.4. India Biochip Market, 2018 - 2030 (USD Million)
    • 6.5.5. Australia
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Competitive Scenario
      • 6.5.5.3. Target Disease Prevalence
      • 6.5.5.4. Australia Biochip Market, 2018 - 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Competitive Scenario
      • 6.5.6.3. Target Disease Prevalence
      • 6.5.6.4. Thailand Biochip Market, 2018 - 2030 (USD Million)
    • 6.5.7. South Korea
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Competitive Scenario
      • 6.5.7.3. Target Disease Prevalence
      • 6.5.7.4. South Korea Biochip Market, 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Latin America Biochip Market, 2018 - 2030 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Target Disease Prevalence
      • 6.6.2.4. Brazil Biochip Market, 2018 - 2030 (USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Target Disease Prevalence
      • 6.6.3.4. Argentina Biochip Market, 2018 - 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. MEA Biochip Market, 2018 - 2030 (USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Target Disease Prevalence
      • 6.7.2.4. South Africa Biochip Market, 2018 - 2030 (USD Million)
    • 6.7.3. Saudi Arabia
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Target Disease Prevalence
      • 6.7.3.4. Saudi Arabia Biochip Market, 2018 - 2030 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Competitive Scenario
      • 6.7.4.3. Target Disease Prevalence
      • 6.7.4.4. UAE Biochip Market, 2018 - 2030 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Competitive Scenario
      • 6.7.5.3. Target Disease Prevalence
      • 6.7.5.4. Kuwait Biochip Market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Position Analysis, 2024
  • 7.4. Company Profiles/Listing
    • 7.4.1. Agilent Technologies
      • 7.4.1.1. Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. PerkinElmer, Inc.
      • 7.4.2.1. Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Illumina, Inc.
      • 7.4.3.1. Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Bio-Rad Laboratories, Inc.
      • 7.4.4.1. Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. Standard BioTools Inc.
      • 7.4.5.1. Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. GE HealthCare
      • 7.4.6.1. Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. IBIOCHIPS
      • 7.4.7.1. Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. LI-COR, Inc.
      • 7.4.8.1. Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. Cellix Ltd
      • 7.4.9.1. Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. Randox Laboratories Ltd.
      • 7.4.10.1. Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global biochip market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global biochip market, by type, 2018 - 2030 (USD Million)
  • Table 4 Global biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 5 North America biochip market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America biochip market, by type, 2018 - 2030 (USD Million)
  • Table 7 North America biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 8 U.S. biochip market, by type, 2018 - 2030 (USD Million)
  • Table 9 U.S. biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 10 Canada biochip market, by type, 2018 - 2030 (USD Million)
  • Table 11 Canada biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Mexico biochip market, by type, 2018 - 2030 (USD Million)
  • Table 13 Mexico biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 14 Europe biochip market, by country, 2018 - 2030 (USD Million)
  • Table 15 Europe biochip market, by type, 2018 - 2030 (USD Million)
  • Table 16 Europe biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 17 Germany biochip market, by type, 2018 - 2030 (USD Million)
  • Table 18 Germany biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 19 UK biochip market, by type, 2018 - 2030 (USD Million)
  • Table 20 UK biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 21 France biochip market, by type, 2018 - 2030 (USD Million)
  • Table 22 France biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Italy biochip market, by type, 2018 - 2030 (USD Million)
  • Table 24 Italy biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Spain biochip market, by type, 2018 - 2030 (USD Million)
  • Table 26 Spain biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 27 Denmark biochip market, by type, 2018 - 2030 (USD Million)
  • Table 28 Denmark biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 29 Sweden biochip market, by type, 2018 - 2030 (USD Million)
  • Table 30 Sweden biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Norway biochip market, by type, 2018 - 2030 (USD Million)
  • Table 32 Norway biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific biochip market, by country, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific biochip market, by type, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 36 China biochip market, by type, 2018 - 2030 (USD Million)
  • Table 37 China biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Japan biochip market, by type, 2018 - 2030 (USD Million)
  • Table 39 Japan biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 40 India biochip market, by type, 2018 - 2030 (USD Million)
  • Table 41 India biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 42 South Korea biochip market, by type, 2018 - 2030 (USD Million)
  • Table 43 South Korea biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Australia biochip market, by type, 2018 - 2030 (USD Million)
  • Table 45 Australia biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 46 Thailand biochip market, by type, 2018 - 2030 (USD Million)
  • Table 47 Thailand biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Latin America biochip market, by country, 2018 - 2030 (USD Million)
  • Table 49 Latin America biochip market, by type, 2018 - 2030 (USD Million)
  • Table 50 Latin America biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Brazil biochip market, by type, 2018 - 2030 (USD Million)
  • Table 52 Brazil biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 53 Argentina biochip market, by type, 2018 - 2030 (USD Million)
  • Table 54 Argentina biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa biochip market, by country, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa biochip market, by type, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 58 South Africa biochip market, by type, 2018 - 2030 (USD Million)
  • Table 59 South Africa biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Saudi Arabia biochip market, by type, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 62 UAE biochip market, by type, 2018 - 2030 (USD Million)
  • Table 63 UAE biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 64 Kuwait biochip market, by type, 2018 - 2030 (USD Million)
  • Table 65 Kuwait biochip market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Biochip market: market outlook
  • Fig. 7 Biochip competitive insights
  • Fig. 8 Parent market outlook
  • Fig. 9 Biochip market driver impact
  • Fig. 10 Biochip market restraint impact
  • Fig. 11 Biochip market: Type movement analysis
  • Fig. 12 Biochip market: Type outlook and key takeaways
  • Fig. 13 DNA chips market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 Cancer diagnostics & treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Gene expression market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 16 SNP genotyping market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 17 Genomics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Drug discovery market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Agricultural biotechnology market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 20 Others market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 21 Protein chips market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Proteomics market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 23 Expression profiling market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 24 Diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 HTS market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Drug discovery market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 27 Others market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 28 Lab-on-chip market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 29 Genomics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 IVD & POC market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Proteomics market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 32 Drug discovery market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Biochip market: End use movement analysis
  • Fig. 35 Biochip market: End use outlook and key takeaways
  • Fig. 36 Biotechnology & pharmaceutical companies market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 37 Academic & research institute market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Hospitals & diagnostic centers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 North America biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 U.S. biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Canada biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Mexico biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Europe biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 UK biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Germany biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 France biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Italy biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Spain biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Denmark biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Sweden biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Norway biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Asia Pacific biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 China biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Japan biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 India biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Thailand biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 South Korea biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Australia biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Latin America biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Brazil biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Argentina biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Middle East and Africa biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 South Africa biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Saudi Arabia biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 UAE biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Kuwait biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Market share of key market players - Biochip market